Immunotherapy of type-I-allergies is regarded as the most efficient treatment option besides allergen avoidance. Different forms of allergen preparations are used as well as different routes of application. Virus-like particles represent a potent vaccine platform with proven immunogenicity and clinical efficacy. The addition of toll-like receptor ligands and/or depot-forming adjuvants further enhances immune cell activation. This article will focus on the function of virus-like particles load...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
If you are the owner of this record, you can report an update to it here: Report update to this record